• FOR SALE: One bedroom executive flat, Lagos, Nigeria | Get details]

Third Possible Ebola Vaccine To Be Sped Through Human Trials In Africa



A third potential Ebola vaccine could be tested on healthworkers in west Africa in December following the announcement of funding to speed it through its first-ever human safety trials, the Guardian reports.

The experimental vaccine developed by the Canadian government and licensed to NewLink Genetics will begin swiftly in healthy volunteers in Europe, Gabon and Kenya, under a program with funding from the Wellcome Trust.

The rVSV-EBOV vaccine is already undergoing initial testing in the United States and is one of two to have been injected into people in clinical trials. The other, from GlaxoSmithKline, is also being tested in Europe and Africa, according to Reuters.

Wellcome said yesterday that 335 volunteers would be vaccinated in total in the new trials- 20 in Germany, followed by 100 in each of Gabon and Kenya, and then 115 in Switzerland.

Canada has donated 800 vials of the vaccine, which was developed by the Public Health Agency of Canada, to be used in the trials.

#Ebola #Reuters #Africa

ebola vaccine trial.jpg